Lenovo Announces New Innovations in Gaming, Software, Visuals, and Accessories for the Holidays
1.9.2023 07:20:00 EEST | Business Wire | Press release
Today, Lenovo announced several new products and solutions at its annual holiday product launch. The new additions to the portfolio – which include AI-tuned innovations in gaming, a groundbreaking 3D monitor, software solutions, versatile accessories, and more – are available to explore here.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230831307965/en/
Lenovo Announces New Innovations in Gaming, Software, Visuals, and Accessories for the Holidays (Photo: Business Wire)
Gaming on the Go: Lenovo Legion™ Gaming Handheld Device and Accessories Untether PC Gaming
The new Lenovo Legion Go is the company’s first Windows gaming handheld device that gives gamers more freedom to game however—and wherever—they want. The Lenovo Legion Go is designed for gamers who will settle for nothing less than top-tier specs and visuals on their handheld device. Along with the new micro-OLED-equipped Lenovo Legion Glasses and new Lenovo Legion E510 7.1 RGB Gaming In-Ear Headphones, the debut of the Lenovo Legion Go is a marked expansion of the Lenovo Legion ecosystem of gaming devices, monitors, accessories, software, and services that empower gamers to immerse themselves in their games.
- The new Lenovo Legion Go brings Windows PC gaming power to a handheld mobile form factor, powered by AMD Ryzen™ Z1 Series processors that bring games to life on its 8.8-inch Lenovo PureSight Gaming Display.
- For gamers who want to take their Lenovo Legion Go portable gaming experience to the next level, the new Lenovo Legion Glasses leverage micro-OLED technology to provide a large screen viewing experience that fits in the pocket.
- For a truly immersive gaming experience, the new Lenovo Legion E510 7.1 RGB Gaming In-Ear Headphones offer hi-res 7.1 surround sound audio with a multifunction inline controller.
The King of Cool: Lenovo Legion 9i is the World’s First AI-Tuned Gaming Laptop with an Integrated Liquid-Cooling System1
The Lenovo Legion 9i (16”, 8) is the first top-of-the-line 16-inch gaming laptop in Lenovo Legion’s ecosystem—and in the world—with a self-contained liquid-cooling system1, designed for gamers and creators with heavy graphic workflow requirements who need a full development studio in their bag. The Lenovo Legion 9i leads the Lenovo Legion lineup that also includes the Lenovo Legion Pro series for competitive gamers and the Lenovo Legion Slim series for gamers who value agility, as well as Lenovo Legion displays and peripherals. Also announced today are the Lenovo Legion 16” Gaming Backpack GB700 and GB400, two backpack options that give gamers a choice between slim and lightweight agility or extra storage without sacrificing protection for their Lenovo Legion 9i (16”, 8) or any other laptops and accessories.
Transforming Digital Workspaces: New Devices and Software Power the Future of Hybrid Work
In addition to new gaming devices, Lenovo is unveiling new cutting-edge tech tools and essentials tailored to empower the dynamic, evolving needs of today's business end-users. Its new monitor, software, and accessories are not only designed to boost the capabilities of today’s remote and hybrid workforces, but also to address significant challenges faced by businesses as they digitize operations across departments. Lenovo research shows that managing a remote workforce and global teams remain central tasks for CIOs.2 That’s why the new offerings integrate impressive processing power, immersive 3D, and advanced security to create a unified, human-centered experience.
- For professional content creators who require immersive 3D visualization, the new ThinkVision™ 27 3D Monitor – a stunning 27-inch, glasses-free, 2D/3D compatible monitor – offers seamless 3D effects and real-time eye-tracking.
- The new Lenovo Wired VOIP Headset and Lenovo Wired ANC Headset Gen 2 are high-quality audio solutions for professionals in hybrid work environments, include an inline call control box, active noise cancellation with the latter, and compatibility with popular conferencing platforms.
- For remote work and to support sustainability efforts, the cloud-based Lenovo Device Manager will roll out enhanced new features that include a comprehensive AI-powered energy management solution that efficiently manages device fleets and optimizes power usage.
- To round out the new line-up are a selection of sophisticated and comfortable carry cases, the Lenovo ThinkPad Professional 16inch Backpack Gen 2, and the ThinkPad Professional 16inch and 14inch Topload Gen 2.
For specific details on all the new products and solutions, see the various releases linked below and the press kit on Lenovo StoryHub.
- The King of Cool: Lenovo Introduces the Legion 9i, the World’s First AI-Tuned Gaming Laptop with Integrated Liquid-Cooling System
- Gaming on the Go: Lenovo Unveils a New Legion Gaming Handheld Device and Accessories that Untether PC Gaming
- Transforming Digital Workspaces: Lenovo Unveils New Devices and Software to Power the Future of Hybrid Work
About Lenovo
Lenovo (HKSE: 992) (ADR: LNVGY) is a US$62 billion revenue global technology powerhouse, ranked #217 in the Fortune Global 500, employing 77,000 people around the world, and serving millions of customers every day in 180 markets. Focused on a bold vision to deliver smarter technology for all, Lenovo has built on its success as the world’s largest PC company by further expanding into growth areas that fuel the advancement of ‘New IT’ technologies (client, edge, cloud, network, and intelligence) including server, storage, mobile, software, solutions, and services. This transformation together with Lenovo’s world-changing innovation is building a more inclusive, trustworthy, and smarter future for everyone, everywhere. To find out more visit https://www.lenovo.com, and read about the latest news via our StoryHub.
1Per an internal research conducted as of June 22, 2023, based on comparisons of gaming computers distributed by global PC manufacturers shipping > 1 million units worldwide annually, contained in a 16" panel size supported with a liquid cooling pump and does not have an external cooling attachment.
2 The Resilient CIO: Lenovo Global Study of CIOs 2023
LENOVO, LENOVO LEGION, and THINKVISION are trademarks of Lenovo. AMD and Ryzen are trademarks of Advanced Micro Devices. Inc. All other trademarks are the property of their respective owners. ©2023 Lenovo Group Limited
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230831307965/en/
Contact information
Wendy Fung, wfung@lenovo.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release
International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release
Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom